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VALIDATION OF THE MILLER FORENSIC ASSESSMENT OF SYMPTOMS TEST 
(M-FAST) IN A CIVIL FORENSIC POPULATION 
 
The Miller Forensic Assessment of Symptoms Test (M-FAST) is a relatively new 
measure shown to be a valid and effective tool for screening psychiatric malingering in 
criminal forensic and psychiatric inpatient settings.  The present study attempts to cross-
validate the M-FAST in civil forensic and neurologic samples.  Three-hundred-eight civil 
forensic patients referred by their attorneys for neuropsychological testing were studied.  
Assessment batteries administered included tests of both psychiatric and neurocognitive 
feigning.  Based on these “gold standards,” 4 sets of contrasts were formed in order to 
examine how the M-FAST performs in identifying psychiatric malingering, 
neurocognitive malingering, any malingering (including either or both types of 
malingering), as well as any malingering among a neurologic subset of this sample.  At 
the level of group discrimination, the M-FAST Total score performed well in all 
contrasts.  However, at the level of individual classification rates, although the M-FAST 
Total score was well supported for identifying psychiatric feigning, when neurocognitive 
malingering was present, performance dropped considerably.  Thus, using the M-FAST 
recommended cutting score of 6, the M-FAST was able to successfully identify 
psychiatric malingering; however, the M-FAST is not an appropriate measure to use for 
identifying neurocognitive malingering within this sample. 
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Chapter One: Introduction 
Validation of the Miller Forensic Assessment of Symptoms Test (M-FAST) in a Civil 
Forensic Population 
 It happens every day: a job interview; an initial meeting with a significant other’s 
parents; calling in sick to work; trying to get out of a school assignment due to illness; 
even a child sitting on Santa’s lap; all situations in which normal individuals manipulate 
the impression they are making in order to achieve a goal.  In the context of the mental 
health field, psychologists need to be concerned not only with assessing, diagnosing, and 
treating psychopathology, but unfortunately also with evaluating whether or not the 
symptom reports they are receiving from a patient are truthful. 
 Due to the private nature of most mental experiences, there is a heavy dependence 
on self-reports in psychological evaluations.  However, there is surprisingly little 
attention in most psychological assessments devoted to assessing the accuracy of 
information presented by clients (Berry, Baer, Rinaldo, & Wetter, 2002).  The importance 
of determining the validity of client self-reports is particularly acute in compensation-
seeking cases.  In such a situation, individuals usually have an external incentive to feign 
or exaggerate symptoms to make themselves appear worse than they actually are.  It is 
this “faking bad” that is of interest here. 
Definition of Malingering 
 The DSM-IV-TR (APA, 2000) does not list malingering as a mental disorder, but 
rather as a V-code under “Additional Conditions That May be a Focus of Clinical 
Attention” (p. 739).  Malingering is defined in this manual as “the intentional production 
of false or grossly exaggerated physical or psychological symptoms, motivated by 
external incentives such as avoiding military duty, avoiding work, obtaining financial 
compensation, evading criminal prosecution, or obtaining drugs” (p. 739).  The key 
points to be noted in this definition are the terms “intentional” and “external incentives.” 
 Malingering must be discriminated from the disorders in the DSM-IV-TR (2000) 
that are also marked by false symptom reports.  For instance, Factitious Disorder is the 
“intentional production of physical or psychological signs or symptoms” (p. 513).  
However, here the motivation is not an external incentive (such as compensation, evading 
criminal prosecution, or avoiding work), but rather “to assume the sick role” (p. 513).  In 
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fact, one criterion for Factitious Disorder is the absence of external incentives (which 
would thereby potentially qualify the behavior as malingering). 
 Malingering also differs from the DSM-IV-TR (2000) disorders of Conversion 
Disorder and other Somatoform Disorders.  In Conversion Disorder, symptoms or deficits 
affecting motor or sensory functioning persist but have no organic basis.  This condition 
differs from malingering in that the symptoms are not intentionally produced and appear 
to meet intrapsychic rather than external goals.  Similarly, the other Somatoform 
Disorders also feature physical symptoms with no medical basis and no conscious 
intention to produce those symptoms.   
Frequency of Malingering 
 The actual base rate of malingering is unknown as malingerers by definition 
attempt to avoid detection.  In part due to this factor, the reported frequency of 
malingering fluctuates widely depending on the study and the population evaluated.  In a 
survey of 320 forensic psychologists by Rogers, Sewell, and Goldstein (1993), 
malingering was estimated to occur in 15.7% of patients in forensic settings and 7.4% in 
nonforensic settings.  A later survey of 221 forensic experts by Rogers, Salekin, Sewell, 
and Goldstein (1993) produced similar results, with estimates of malingering at 17.4% for 
forensic and 7.8% for nonforensic settings.  These findings are slightly higher than those 
reported by Frederick et al. (2000), and Heinze and Purisch (2001) who found roughly 
13% of defendants being evaluated for competency to stand trial to be malingering.  
Alternatively, Lewis, Simcox and Berry (2002), using an objective indicator of 
psychiatric feigning in consecutive cases, found 45% of individuals undergoing 
assessment for competency to stand trial to be feigning symptoms.   
 Mittenberg, Patton, Canyock, and Condit (2002) also found high estimated base 
rates of malingering in a survey of board certified clinical neuropsychologists.  Rates 
varied not by geographical region or practice settings, but rather by the population of 
interest.  For example, estimated base rates of malingering were 29% for personal injury, 
30% in disability cases, 19% of criminal cases, and 9% in medical cases.  Thirty-nine 
percent of mild head injury patients were said to be malingering, as were 35% of those 
with fibromyalgia/chronic fatigue; 31% of chronic pain, 27% of neurotoxic exposure, and 
22% of electrical injuries.  Additionally, Mittenberg, et al. (2002) indicated that if 
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variance due to the source of referral (plaintiff vs. defendant) was controlled, base rates 
would be 2-4% higher. 
Although these latter estimated base rates of malingering are alarming enough, it 
is important to note that these survey data may be underestimates of the base-rates of 
malingering because they likely represent only the number of people who have been 
“caught” feigning symptoms, excluding those who have been “successful.”  Thus, these 
estimates may be a “floor” rather than an accurate estimate. 
Types of Malingering and Detection Strategies 
 Current research in malingering distinguishes two major forms: psychological and 
neurocognitive.  Psychological malingering involves feigned reports of psychological 
symptoms such as hearing voices or experiencing delusions.  In contrast, neurocognitive 
malingering involves feigning deficits of cognitive abilities by deliberately performing 
poorly on tests of memory and problem solving.  Invalid psychological symptom reports 
can take many different forms.  For instance, a test-taker could respond defensively, feign 
psychopathology, or answer inconsistently (Rogers, 1997).  Rogers outlines these 
response sets and the methods for detecting their presence as follows.   
Psychological feigning often involves reports of rare symptoms, indiscriminant 
symptom endorsement, obvious symptoms, and improbable symptoms (Rogers, 1997).  
Knowledge of these “faking” strategies has guided the development of some instruments 
for detection of malingering.  For example, both the Structured Interview of Reported 
Symptoms (SIRS) and the Miller Forensic Assessment of Symptoms Test (M-FAST; 
Miller, 2001) make use of these types of strategies via a variety of scales to detect 
malingering.  These scales will be discussed in depth later. 
Scales developed to detect psychological malingering take two broad forms.  The 
sole purpose of the test may be the detection of malingering, as is the case with the 
Structured Inventory of Malingered Symptoms (SIMS; Smith, 1992) and the Miller 
Forensic Assessment of Symptoms Test (M-FAST; Miller, 2001).  Alternatively, some 
tests include both measures of psychological functioning and validity scales to determine 
whether or not the test-taker is responding honestly (Berry et al., 2002).  For example, 
multiscale tests of psychopathology such as the MMPI-2, MCMI-III, and the PAI have 
incorporated scales to detect profile validity. 
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As previously noted, in contrast to psychological malingering, cognitive 
malingering is thought to involve the denial of abilities (Rogers, 1997).  Here, the test-
taker deliberately performs below capacity on cognitive tests in order to portray 
significant deficits.  Bender and Rogers (2004) describe a variety of strategies to detect 
neurocognitive feigning, including Floor Effect, Magnitude of Error, Performance Curve, 
and Symptom Validity Testing.  Detection via Floor Effects involves the malingerer’s 
unawareness of which items are too simple to be failed plausibly, such as inability to 
recall one’s own name.  In this case, those feigning cognitive impairment end up 
performing worse than those with genuine severe deficits.   Magnitude of Error 
presupposes that the feigner will not be concerned with how far astray his/her incorrect 
answer is from the correct one, leading to implausible answers.  The Performance Curve 
strategy examines patterns of answers across items of varying difficulty; malingerers tend 
not to consider such patterns when deliberately answering incorrectly.  In its original 
form, Symptom Validity Testing involved forced choice problems with two alternatives 
provided.  It was thus possible to examine the failure rate of the feigning individual to 
determine if it dropped statistically significantly below chance using the binomial 
theorem.  If so, there was strong objective evidence that the individual was deliberately 
choosing to answer incorrectly.   
Symptom Validity Testing has proven the most popular framework for developing 
new neurocognitive malingering tests.  However, scoring significantly below chance 
(p<.05) was shown to be uncommon among analog malingerers (Guillmette et al., 1994), 
leading to changes in interpretive strategies.  Symptom Validity Testing eventually 
shifted to using cutoff scores derived from the scores of genuinely impaired but non-
compensation seeking patients to determine normative standards of performance 
(Weinborn, Orr, Woods, Conover, Feix, 2003).  Typically, these cutting scores are much 
higher, and thus much more sensitive than the significantly below chance criterion, while 
retaining high specificity.    
 Neurocognitive malingering tests based on the Symptom Validity Testing and 
normative cut score approach include, but are not limited to, the Test of Memory 
Malingering (TOMM; Tombaugh, 1997), the Victoria Symptom Validity Test (VSVT; 
Slick, Hopp, Strauss, & Pinch, 1994), and the Digit Memory Test (DMT; Hiscock & 
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Hiscock, 1989).  These tests are widely used in clinical settings and are well-validated, as 
will be reviewed below. 
Malingering Methodology 
 In order to evaluate the validity of instruments designed to detect malingering, 
several different research designs are commonly used.  These include Differential 
Prevalence designs, Simulation designs, and Known-Groups designs, as described by 
Berry, Baer, Rinaldo and Wetter (2002).  Differential Prevalence designs compare groups 
thought to differ in rates of malingering, such as, compensation-seeking vs. non-
compensation seeking patients.  These groups are compared in their performance on the 
malingering test or scale under investigation.  Although this design does address 
construct validity in that the prevalence of failing is predicted to be different for the two 
groups, its major limitation is that there is no way to assess the accuracy of the test, as the 
malingering status of individuals in the two groups is unknown. 
 Simulation studies are experimental designs, meaning that subjects are randomly 
assigned to groups and a manipulation takes place (Rogers, 1997; Pedhazur & Schmelkin, 
1991).  In such a design, groups are compared on one or more malingering scales.  
Malingering groups are often composed of normal individuals who are typically offered 
small incentives to “simulate” a certain type of response style, such as faking-good or 
faking-bad.  A clinical group of truly impaired individuals is often incorporated as a 
comparison group.  This type of study is useful in the initial validation of a study because 
it is high in internal validity, as it is known whether or not a participant was actually 
malingering.  However, a limitation of this type of design is that it may not generalize 
well to a real world setting.  Participants such as college undergraduates typically do not 
match on demographic variables when compared to a group of litigants to whom the test 
would usually be administered.  Furthermore, the small incentives (such as money) 
offered in a research study pale in comparison to the real-world repercussions 
encountered by actual litigants (such as losing custody of one’s children or being sent to 
jail). 
The final design commonly used in malingering research is a non-experimental 
design (meaning no manipulation takes place) called a Known-Groups design.  Known-
Groups designs use a gold standard to assign clinical participants to feigning or honest 
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groups.  In this case, the independently identified clinical malingerers are compared with 
clinical test-takers known to be answering honestly.  This type of design is higher in 
external validity than the Simulation design because the findings are more easily 
generalized to real-world situations.  However, there are some limitations.  For instance, 
a ceiling effect may be present because the validity of the measure being tested can only 
be as high as the gold standard measure used to classify the participants as malingering or 
honest.  Moreover, the participants classified as malingering may not be representative of 
all malingerers.  After all, these participants were the ones incompetent enough to be 
caught.  Successful malingerers might be using a more sophisticated strategy that allows 
them to avoid detection.  Finally, as there is no experimental manipulation in Known-
Groups designs, differences in groups cannot necessarily be attributed solely to the 
independent variable (as one may do in simulation designs). 
Available tests for malingering detection such as the SIRS (reviewed below) have 
been shown to be reasonably accurate.  However, they are often limited by significant 
time requirements.  Thus, validation of a briefer screening measure that could be 
administered to all compensation-seeking evaluees would be desirable.  This study will 
cross-validate such a brief measure, the M-FAST, with a Known-Groups design.  For the 
current study, this design will be used to separate compensation seeking neuropsychiatric 
evaluees into several groups: those demonstrating any type of malingering, those who are 
malingering psychiatric symptoms, and those who are malingering neurocognitive 
symptoms.  In order to classify participants, the standard used for psychiatric malingering 
was participants’ score on the Structured Interview of Reported Symptoms (SIRS; 
Rogers, Bagby, & Dickens, 1992), while the standard for neurocognitive malingering was 
a combination of the Victoria Symptom Validity Test (VSVT), the Test of Memory 
Malingering (TOMM), and the Letter Memory Test (LMT).  The psychometric properties 
of the M-FAST will then be examined across feigning and honest groups. 
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Chapter Two:  Methods 
Participants 
The 308 participants included 203 men and 104 women aged 18 and older (M = 
41.31, SD = 11.25) who were referred to Dr. Robert P. Granacher at the Lexington 
Forensic Institute (LFI), in Lexington, KY, for neuropsychological evaluation.  All 
participants were involved in cases in which they were seeking compensation from 
insurance companies for injuries, or other sources of compensation such as personal 
injury, workers compensation, Social Security or Disability.  Participants could be 
referred by either the plaintiff or the defense attorneys.   
Participants were those individuals from this practice who agreed via written 
consent to contribute their data, in an anonymous fashion, to this study.  Due to IRB 
restrictions, it was not possible to compare consenting and non consenting evaluees.  
Although demographic characteristics were not used as selection criteria for the proposed 
study, group differences on characteristics such as age, sex, education and ethnicity are 
analyzed. 
Instruments 
 All tests and procedures in the study were routinely used in Dr. Granacher’s 
practice.  Every participant underwent a clinical interview and neuropsychiatric 
examination, as well as completed a background questionnaire, and received a 
neuropsychological battery including both psychiatric and cognitive malingering tests.  
While the clinical interview and neuropsychiatric examination were performed by Dr. 
Granacher, a board-certified neuropsychiatrist, the rest of the evaluation was conducted 
by supervised, master’s level psychometrists.  
 The background questionnaire was a self-report measure containing questions 
regarding the client’s presenting problem, activities of daily living, medical and 
psychological history, social history, family history, legal history, employment/vocational 
history, educational and military backgrounds. 
Although the neuropsychological portion of the assessment varied somewhat 
depending on the situation and presenting complaints, most participants received the 
following tests administered via standard instructions:  Ruff 2 & 7 Test, Brief Test of 
Attention, Trail-Making Test, Boston Naming Test, Controlled Oral Word Association 
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Test, WRAT-III Reading Subtest, Wechsler Test of Adult Reading, Grooved Pegboard 
Test, Finger Oscillation Test, Hand Dynamometer Test, Wisconsin Card Sorting Test, 
Wechsler Adult Intelligence Scale, 3rd Edition, and the Wechsler Memory Scale, 3rd 
Edition.   
In addition, the Test of Memory Malingering (TOMM; Tombaugh, 1997), 
Victoria Symptom Validity Test (VSVT; Slick, Hopp, Strauss & Pinch, 1994; Slick, 
Hopp, Strauss & Thompson, 1997), and the Letter Memory Test (LMT; Inman, Vickery, 
Berry, Lamb, Edwards, & Smith, 1998) were administered in order to assess for feigning 
of cognitive deficits.   
Similarly, the assessment included measures of psychopathology including the 
Minnesota Multiphasic Personality Inventory – 2nd edition (MMPI-2: Butcher, Graham, 
Ben-Porath, Tellegen, Dahlstrom, & Kaemmer, 2001).  In order to assess feigning of 
psychiatric symptoms, the Structured Interview of Reported Symptoms (SIRS: Rogers, 
Bagby, & Dickens, 1992) and the Miller Forensic Assessment of Symptoms Test (M-
FAST: Miller, 2001) were administered.  Descriptions of the feigning tests are presented 
below. 
Victoria Symptom Validity Test (VSVT):  The VSVT, developed by Slick, Hopp, 
Strauss, and Pinch in 1994, is a computerized and revised version of Hiscock and 
Hiscock’s Forced-Choice Memory Test.  In this test, there are 48 items presented in 3 
blocks of 16 items each.  In each block, a five-digit number is presented for 5 seconds as 
a stimulus on a computer screen.  This is followed by a blank interval.  This blank 
interval lasts 5 seconds in the first block, 10 seconds in the second, and 15 seconds in the 
third.  The participant must then choose the stimulus from a distractor (only 2 choices 
presented).  The VSVT includes both “easy” items (forced choice answers sharing no 
common digits; ex. 42905 and 76381) and “difficult” items (the distractor is identical to 
the stimulus with the exception of the transposition of two digits; e.g. 51284 and 51824).  
An equal number of easy and difficult items are found in each block.   
 The original validation study showed that the VSVT correctly classified 100% of 
honest controls and 80% of subjects instructed to feign memory deficits, indicating that 
the VSVT demonstrated good sensitivity (Slick et al., 1994).  Using traditional guidelines 
of setting a cut-off a score significantly below chance (p<.05), only 20% of analog 
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malingerers were identified. By adjusting the cut-off scores to a less conservative cut off 
that again correctly classified all honest controls, the VSVT proved more sensitive at 
distinguishing cases of motivation problems and classification rates greatly improved 
(Slick et al., 1994).  It is important to note, however, that this study was limited by the 
use of undergraduates as subjects. In a later study using both compensation seeking 
and non-compensation seeking patients, specificity on the VSVT was found to be 100%, 
while sensitivity was reported to be poor initially (Slick, 1999).  Slick, Hopp, Strauss, and 
Spellacy (1997) showed that by using a 3-level cut score system (identifying test takers as 
malingering (performance significantly below chance, p<0.05), questionable 
(performance within a 90% confidence interval around chance), or valid (performance 
significantly above chance, p<0.05) according to cutting scores based on normative data) 
improved the sensitivity of the VSVT to 91%, while having little effect on the specificity.  
Findings by Grote, Kooker, Garron, Nyenhuis, Smith and Mattingly (2000) supported 
previous research, demonstrating that non-compensation seeking patients perform well on 
the VSVT, whereas patients seeking compensation tended to perform poorly.  Grote et al. 
(2000) recommended a cutting score of <90% in order to maximize the discrimination of 
these samples.  Furthermore, Slick et al. (2003) reported that even non-litigants with 
neurological diseases marked by severe amnesia and memory problems attained near 
perfect scores on the VSVT.  These results suggest that the VSVT is a useful tool in 
differentiating malingering individuals from those with true cognitive deficits in a 
compensation seeking setting. 
Test of Memory Malingering (TOMM):  Developed by Tombaugh in 1996, the 
TOMM is a test of feigned memory deficits that involves line-drawn pictures as stimuli.  
It consists of two learning trials, each of which includes a study and a test phase, 
followed 20 minutes later by a delayed retention trial.  In each study trial, the same 50-
line drawn pictures are presented for 3 seconds each.  During each test phase, each target 
is paired with a new line drawing (a distractor), and the test-taker is asked to choose 
which drawing he or she recognizes.  The delayed retention trial is administered 20 
minutes later, and consists of only the test portion again with novel foils.  All three trials 
of the TOMM can be administered in approximately 15 minutes. 
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 By using pictures as stimuli, the perceived difficulty of the TOMM is thought to 
exceed the actual difficulty (Tombaugh, 1997).  Therefore, a person who is trying to 
feign cognitive problems would be more likely to perform poorly on this test, even 
though it is generally easy and truly impaired individuals do rather well.  Using a cutting 
score of 45 (<90% correct) on the 2nd trial, Tombaugh (1997) found that the TOMM is 
relatively insensitive to genuine cognitive impairment.    Using this cutting score, 
demented and moderate/severe cognitively impaired groups scored an average of 92% 
and >97% correct, respectively (Tombaugh, 1997).  In addition, the TOMM was shown 
to be uncorrelated with age and education, with these two factors accounting for only 2% 
of the variance in test scores (Tombaugh, 1997).   
Later research also indicated that scores were insensitive to affective state as well; 
scores below 45 could not be attributed to depression. Additionally, neurological 
impairment, age and education were not significantly related to TOMM scores (Rees, 
Tombaugh, & Boulay, 2000).  Further research has suggested that the TOMM has 
excellent sensitivity and specificity using a cutting score of <45 (Rees, Tombaugh, 
Gansler and Moczynski, 1998).  Reported values have ranged from 100% specificity and 
84% sensitivity with a simulation design including introductory psychology students, to 
100% specificity and 100% sensitivity with a community sample. 
 Delain, Stafford and Ben-Porath (2003) examined the TOMM in a criminal court 
forensic setting.  The study used a group of 64 criminal defendants from both rural and 
urban areas who were court-ordered to undergo psychological evaluation for reasons 
including competency to stand trail and criminal responsibility.  Of these 64 individuals, 
29 fell below the recommended cutoff score of 45 on the TOMM Trial 2 and were thus 
labeled as malingering.  The scores for these malingering defendants were comparable to 
those found in the original sample, with means and standard deviations of 36.4 (12.03), 
40.86 (13.36), and 39.80 (14.76) on Trial 1, Trial 2, and the Retention Trial, respectively.   
The combination of findings from both simulation and known groups designs 
suggests that the TOMM is well suited for the detection of malingering in people feigning 
memory impairments. 
The Letter Memory Test (LMT):  In response to the need for additional, well-
validated motivational tests to assess client effort, Inman, Vickery, Berry, Lamb, 
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Edwards, and Smith (1998) developed the Letter Memory Test (LMT).  This test is in 
reality quite easy; however, it steadily increases in face difficulty as the test progresses.  
In this forced-choice, computer administered test, 45 items consisting of combinations of 
consonant letters are presented.  After a 5-second delay, the test-taker chooses the target 
combination from a distractor or group of distractors.  The LMT increases in face 
difficulty by crossing the number of letters in the stimuli to be remembered (3, 4 or 5) 
with the number of choices from which the target stimulus must be recognized (2, 3 or 4) 
in 9 blocks of five trials each.  Thus, the first block of trials involves a 3 letter stimulus 
that must be chosen from 2 alternatives, the next a 4 letter stimulus that must be chosen 
from 2 alternatives, etc.  These changes were intended to manipulate face difficulty level 
without affecting actual difficulty level. 
Initial validation of the LMT by Inman et al. (1998) showed that there was no 
difference in performance on the LMT between neurologically impaired, moderately 
depressed, brain damaged, and normal control groups.  Furthermore, these groups scored 
much higher than both coached and non-coached analog malingerers (Inman et al., 1998).  
Thus, those feigning cognitive symptoms performed much more poorly on the LMT than 
genuine patients. 
Results from this initial validation study demonstrated a cutting score at or above 
93% (< 93% classified as feigning) to have a mean specificity and sensitivity of 100% 
and 84.3%, respectively (Inman et al., 1998).  This translates into positive and negative 
predictive powers of 100% and 98% at a 15% base rate, 100% and 95% at a 21% base 
rate, and 100% and 87% at a 48% base rate (Inman et al., 1998). 
This cutting score was later cross-validated using a sample of both head injured 
and analog malingerers (Inman & Berry, 2002).  In this study, which examined multiple 
tests of malingering among a neuropsychological battery, the LMT was found to have a 
specificity of 100%, a sensitivity of 73%, and an overall hit rate of 87%.  The LMT, 
along with the Digit Memory Test (Hiscock & Hiscock, 1989), had the highest levels of 
sensitivity and specificity of all the tests studied, including the 21-Item Test (Iverson et 
al., 1991) and the 15-Item Test (Rey, 1964) (Inman & Berry, 2002). 
Orey, Cragar, and Berry (2000) examined the LMT across three different levels of 
motivation (high, low, and standard) in mildly head-injured college students.  While this 
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study was similar to the others in terms of results (specificity was 100% and sensitivity 
was a moderate 58%), it differed in the administration of the LMT.  A modified, card-
based version of the test was used; however, this test had not been validated and 
compared directly to the originally validated computer-based version (Orey, Cragar, and 
Berry, 2000). 
In 2004, Vickery et al. examined the possibility that head-injured patients may be 
better suited to feign cognitive deficits due to their experience with brain trauma.  This 
study again showed the LMT to be relatively insensitive to the presence of head injury 
while being quite sensitive to malingering by both analogue malingerers and those with a 
head injury who were instructed to malinger.  Specificity was quite high, sensitivity was 
moderately high, and head injured patients showed no superiority in feigning cognitive 
symptoms (Vickery et al., 2004). 
As can be seen from the studies above, the LMT is a well validated test of 
neurocognitive malingering that is appropriate for the detection of malingering among 
neurologically impaired individuals.   
Minnesota Multiphasic Personality Inventory  – 2 (MMPI-2) Fake Bad Scales:  
The MMPI-2 is a well validated and widely used assessment of personality.  In addition 
to the test’s Clinical scales which measure pathology, the instrument has Validity scales 
which measure the consistency of response sets, faking bad and faking good.  The fake 
bad scales include scales F, Fb, and F(p).   
The F scale contains items that are infrequently endorsed and are often indicative 
of individuals who are trying to portray themselves in a negative light.  The Fb scale is 
quite similar to the F scale, but covers items on the latter part of the MMPI-2.  The last of 
these fake bad scales, F(p), examines symptoms infrequently endorsed even amongst a 
psychiatric sample.  Studies have shown that the F(p) adds incremental validity to the F 
scale (Graham, Watts, & Timbrook, 1991; Arbisi & Ben-Porath, (1995).  On all of these 
scales, a T-score of greater than 100 raises the possibility of malingering.  
Structured Interview of Reported Symptoms (SIRS): Developed by Rogers, 
Bagby, & Dickens (1992), the SIRS is a 172-item structured interview designed 
exclusively to identify psychiatric malingering.  The test consists of true/false questions 
that comprise eight primary scales (used in the classification of individuals as honest or 
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feigning), and five supplementary scales (used for interpretation of response styles).  The 
primary scales include examination of Rare Symptoms (RS), Symptom Combinations 
(SC), Improbable and Absurd Symptoms (IA), Blatant Symptoms (BL), Subtle 
Symptoms (SU), Selectivity of Symptoms (SEL), Severity of Symptoms (SEV), and 
Reported vs. Observed Symptoms (RO).   
Dependent on the number of items endorsed on each scale, the scales are 
categorized as in the Definite Feigning, Probable Feigning Indeterminate, or Honest 
responding ranges.  A person is classified as malingering if a) at least one of the primary 
scales falls in the Definite Feigning range, b) three of the primary scales fall into the 
Probable Feigning range, or c) the overall Total raw score is greater than 76. 
Due to concern about mislabeling an honest responder as malingering, the SIRS 
has been designed to minimize the number of false positives.  Thanks to a number of 
validation studies that have shown the SIRS to have high classification accuracy and 
positive predictive power, the SIRS has come to be known as a “gold standard” to which 
other tests of psychiatric malingering are often compared.  However, one practical 
limitation of the SIRS is that it requires 30-45 minutes of direct clinician time to 
administer.  With current pressure from managed care to reduce clinician time, an 
efficient and shorter screening method for detection of false psychiatric symptoms would 
be desirable.   
Miller Forensic Assessment of Symptoms Test (M-FAST):  The M-FAST was 
developed by Miller (2001) as a brief screening measure to aid in the detection of 
malingered psychopathology.  It was intended to limit the number of false negatives, such 
that those who “pass” the M-FAST need no further testing for psychiatric feigning.  In 
order to accomplish this, the M-FAST was designed to have high sensitivity and hence 
high negative predictive power (NPP) in most settings.  Furthermore, with only 25 items, 
the M-FAST was developed to take a minimal amount of time to administer (roughly 5 
minutes).  In addition, it is given in the form of an interview, thereby bypassing the issue 
of illiteracy and low reading ability among test takers.  The M-FAST has been validated 
on individuals over the age of 18 through the use of both simulation and known-groups 
designs, and has been shown to generalize across race, gender, and literacy status (Miller, 
in press).   
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The test was rationally derived to detect psychiatric malingering using the 
aforementioned detection strategies identified by Rogers (1997).  The scales are as 
follows (Miller, 2001): 
a) “Unusual hallucinations (UH): Individuals who are attempting to 
malinger have difficulty determining accurate symptoms of mental 
illness.  Thus, in many cases, malingerers will endorse symptoms that are 
actually rare in psychiatric populations.  For example, malingerers may 
endorse “I hear voices that last continuously for days,” whereas bona fide 
patients report that the voices are intermittent. 
b) Reported versus observed (RO):  Potential malingerers often report 
symptoms that do not correspond with their actual behavior.  For 
example, malingerers will state that they cannot sit in a chair without 
looking under it many times to see if anything is there even though they 
do not demonstrate this behavior during the interview.   
c) Extreme symptomatology (ES):  Potential malingerers endorse an 
unlikely number of symptoms and endorse symptoms that are more 
extreme or severe than actual psychiatric patients.  For example, 
malingerers may endorse such items as “I hear voices every day at 4:30 
pm when nobody is around.” 
d) Rare combinations (RC):  Potential malingerers will endorse symptoms 
that rarely or never coexist.  For example, a malingerer may endorse 
“Some days I have major mood swings, where for awhile I feel great and 
then I feel depressed” and then endorse “this only happens when I wash 
my hands over and over.” 
e) Negative image (NI):  Individuals attempting to malinger may believe 
that they should be seen in a negative light.  For example, malingerers 
will often endorse such items as “People don’t like me, even if I’m nice 
to them.” 
f) Unusual symptom course (USC):  Individuals who are attempting to 
malinger do not understand that mental illness usually has a gradual 
onset and thus will report a sudden onset of their mental illness or a 
sudden cessation of symptoms.  For example, malingerers tend to 
endorse an item such as “My mental illness appeared suddenly, so one 
day I woke up and it was there.” 
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g) Suggestibility (S):  Potential malingerers may be suggestible when they 
feel that endorsing a symptom could make them look mentally ill.  For 
example, after telling the patient at the beginning of the interview that 
people with severe mental illness cannot concentrate for a long time 
without seeing little green men, many malingerers, at the end of the 
interview, will report that they see little green men.” 
(Miller, 2004, p. 271) 
 The Total Score on the M-FAST is calculated by summing the total number of 
items endorsed.  At least 23 items must be completed in order to interpret the score, 
although any interpretation based on less than 25 items is to be avoided, as the shorter 
test may be less reliable (Miller, 2001).  Miller recommends a Total Score of 6 as a 
cutting score; however, she also gives the option of a second level of interpretation based 
on scale scores.  Specifically, the UH, RC, RO and ES scales have been shown to 
differentiate malingerers from honest test takers (Miller, 2001).  The manual recommends 
suspicion of malingering if RO ≥ 1, ES ≥ 2, RC ≥ 2, and UH ≥2. 
 The cutting score of 6 has been cross-validated in a number of studies (Miller, 
2001; Miller, 2004; Jackson, Rogers, & Sewell, 2005; Guy & Miller, 2004).  Miller’s 
(2001) original studies showed the cutting score of 6 maximized NPP (.97) without 
decreasing the PPP (.68) to a significant extent using a clinical sample of forensic 
psychiatric patients.  Similar findings were found for a nonclinical sample of college 
undergraduates, with NPP = .94 and PPP = 1.00.  Sensitivity and specificity rates were 
.93 and .83 for the clinical sample, respectively, and .93 and 1.00 for the nonclinical 
sample, respectively.  In these initial validation studies, coefficient alphas ranged from 
.44 - .82 for the subscales, and .92 for the total score. 
 In a sample of 50 incarcerated males, Guy & Miller (2004) showed a cutting score 
of 6 to have similar properties.  Using the SIRS as a gold standard, the M-FAST had NPP 
= .89, PPP = .78, specificity = .83, and sensitivity = .86.  Miller (2004) also examined a 
group of 50 criminal defendants found incompetent to stand trial by reason of mental 
illness.  Again, using the SIRS as a gold standard, the M-FAST had sensitivity = .93, and 
specificity = .83.  She reported a very large effect size of r = .81. 
 Jackson, Rogers, & Sewell (2005) examined the M-FAST in a sample of 
incarcerated men and women, half of whom were asked to feign psychopathology.  They 
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also included a sample of forensic inpatients seeking to have their competency restored.  
The SIRS was, once again, used as a gold standard.  Using the total score, internal 
consistency was high for the M-FAST at alpha = .91.  Internal consistencies for the 
subscales ranged from .63-.65.  Effect sizes were again large using the total score, 
ranging from d = 1.47 for the simulating inmates vs. those trying to have competency 
restored, to d = 3.18 for those identified as malingering by the SIRS vs. controls.  Again, 
using a cutting score of 6, PPP = .74, NPP = .91, sensitivity = .76, specificity = .90, and 
the overall hit rate was .86. 
 Although previous literature has shown the M-FAST to be a useful clinical tool, 
further validation would be helpful to address several issues.  Most of the research that 
has been done on the measure has come out of Miller’s own lab, and the majority of it 
has been based on inmates and psychiatric inpatients.  Research on a civil forensic 
sample is needed, as well as further validation from an outside lab.  In addition, Berry & 
Schipper (in press) highlight the need to address the validity of the M-FAST in 
neurologic patients.  As no previous studies studied the M-FAST in patients with 
neurologic disorders or a history of head injuries, the current study will address this issue 
in a neuro-psychiatric setting.   
Procedure 
 All participants evaluated by Dr. Granacher reviewed a consent form potentially 
allowing their data to be used for research purposes.  Data for the present study come 
only from evaluees who provided permission for their results to be used.  All participants 
completed the 22-page background questionnaire.  Those unable to complete the 
questionnaire on their own had someone help them.  The participants were then 
administered Dr. Granacher’s standard battery of psychological tests as part of an 
evaluation examining the presence and severity of psychological and cognitive 
symptoms.  This battery included the TOMM, VSVT, LMT, SIRS, and M-FAST.  The 
average time for completion of testing was approximately 5 ½ hours. 
 In order to ascertain how the M-FAST performs in detecting various types of 
malingering (psychiatric, neurocognitive, or feigning of any kind), several group 
contrasts were created.  The first contrast included an Any Malingering (AM) group 
compared to a Both Honest Group (BH).  In order to be categorized in the Any 
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Malingering group, an individual had to be identified as malingering on either the SIRS, 
or two or more of the neurocognitive tests of malingering (TOMM, VSVT, or LMT).  
Therefore, these individuals were faking psychiatric and/or neurocognitive symptoms.  In 
order to be identified as part of the Both Honest group, an individual had to be identified 
as honest on all the malingering tests.  Remaining participants who did not meet criteria 
for the AM or BH groups were categorized as Any Intermediate (AI), and were excluded 
from this contrast. 
The next contrast included Psychiatric Malingering (PM) vs. Psychiatric Honest 
(PH) groups (as determined by the SIRS).  Following recommendations in the SIRS’ 
manual (Rogers, Bagby, & Dickens, 1992) individuals could be assigned to the 
Psychiatric Malingering (PM) group if 1) the Total raw score on the SIRS exceeded 76, 
2) at least one SIRS Primary scale was categorized as Definite Malingering, or 3) three or 
more SIRS Primary scales were categorized as Probable Malingering.  Participants were 
included in the Psychiatric Honest (PH) group if they did not meet criteria for the PM 
group and had at least six of the Primary SIRS scales classified as Honest.  Participants 
not meeting criteria for PM or PH groups were placed in a third Psychiatric Indeterminate 
(PI) group and excluded from this contrast. 
 The Neurocognitive groups were formed based upon performance of individuals 
on the tests of neurocognitive effort, namely, the LMT, VSVT, and TOMM.  Participants 
classified as malingering on at least two of these tests were placed in the Neurocognitive 
Malingering (NM) group.  Participants classified as honest on all three of the tests were 
placed in the Neurocognitive Honest (NH) group.  A third Neurocognitive Indeterminate 
(NI) group included those individuals who did not meet criteria for either the NM or NH 
groups, who were excluded from this contrast. 
 As previously stated, results from neurological participants were also of interest.  
Therefore, patients with a history of neurological disorders (head injury, neurological 
disease, stroke) were selected from the greater sample of civil forensic participants.  
These neurological patients comprised 33.8% of the overall civil forensic sample.  
Therefore, a fourth and final contrast was evaluated in which neurological patients 
malingering psychiatric or neurocognitive symptoms were compared to those who had 
answered honestly on both the psychiatric and neurocognitive tests (NAM vs. NBH).  
17  
 
 
 
The following analyses, therefore, address the issue of the validity of the M-FAST in a 
civil forensic sample as well as in neurologic patients.   
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Results 
Table 1 provides base rate data for each type of malingering.  It can be seen that 
the prevalence of AM is 27.6%, PM is 7.5%, NM is 24.4%, and NAM is 24.0%.  The 
following analyses will examine how each group compared on background variables and 
the tests of interest – the MMPI-2 (Validity and Clinical scales), the Neurocognitive tests 
(LMT, TOMM Trial 2, and the VSVT Difficult and Total scores), the SIRS, as well as 
the M-FAST.  For each contrast, the results from the tests used to determine group 
assignment will not be presented, as these differences are confounded with selection 
criteria. 
Any Malingering vs. Both Honest Groups (AM vs. BH) 
 The first contrast compared individuals who feigned on the psychiatric and/or the 
neurocognitive tests of malingering.  As previously noted, participants were classified as 
Any Malingering (AM) if they were identified as malingering either on the SIRS or on 2 
or more of the neurocognitive malingering tests (LMT, TOMM Trial 2, and VSVT 
Difficult or Total).  This AM group was then compared to those individuals classified as 
honest on both the psychiatric and neurocognitive malingering tests (BH).  The base rate 
of any type of malingering (regardless of whether it is neurocognitive or psychiatric) was 
27.6% for this sample. 
 Background variables.  Table 2 shows age and education variables for the AM 
and BH groups.  No statistically significant differences were found between groups.  
Table 3 shows additional demographic and claim type information, again with no 
statistically significant differences found between the groups.  Thus, the 2 groups were 
comparable on these potentially confounding variables. 
 MMPI-2 Scores.  Data from the MMPI-2 Validity scales appear in Table 4.  The 
Infrequency scales (F, Fb, F(p), F-K) were statistically significantly higher in the AM 
group, whereas the S and K scales were significantly lower (indicating no attempt to 
answer in a defensive or superlative manner).  Effect sizes ranged from d = 0.71 (for 
F(p)) to d = 1.59 for the F scale.  K and S had effect sizes of d = -0.50 to -0.45, 
respectively.  These results suggest significantly more psychiatric feigning in the AM 
group than in the BH group. 
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 Table 5 shows data from the MMPI-2 Clinical scales which were also statistically 
significantly higher for the AM group, with the exception of scales 4, 5 and 9.    Effect 
sizes ranged from d = 0.73 (for scale 3) to d = 1.46 (scale 8).  It is interesting to note that 
scale 8 had the greatest effect size, indicating that participants who were grouped as 
malingering in any way reported severe, psychotic symptomatology on the MMPI-2.  
Overall, the malingering group was endorsing psychiatric symptoms more frequently 
than the honest group. 
 M-FAST Scores.  In Table 6 it can be seen that with the exception of scale RO, all 
other M-FAST scales significantly differentiated the BH and AM groups.  Effect sizes 
ranged from d = 0.48 (scale S) to d = 1.36 (Total score).  These findings raise the 
possibility that, in an actual civil forensic setting or among individuals with neurological 
disorders (when an examiner is unaware as to whether the presenting individual will 
attempt to malingering psychiatric or neurocognitive symptoms), the M-FAST may be 
useful, although individual classification rates must be evaluated as well. 
Psychiatric Malingering vs. Psychiatric Honest Groups (PM vs. PH) 
 The next contrast addresses the ability of the M-FAST to identify psychiatric 
malingering vs. psychiatric honest individuals.  A total of 23 participants determined to 
be malingering psychiatric symptoms according to the SIRS were classified as 
Psychiatric Malingerers (PM), whereas those determined to be honest according to the 
SIRS (N = 172) were classified as Psychiatric Honest (PH) responders.  Thus, as 
indicated earlier, the base rate of malingering of the PM group was 7.5% relative to the 
rest of this sample. 
 Background variables.  Table 7 shows age and education data for the two groups.  
As hypothesized, no statistically significant differences were found.  Table 8 presents 
other demographic and claim variables for the PM and PH groups.  Again, no statistically 
significant differences were found.  These findings suggest the 2 groups were comparable 
on these potential confounding variables. 
 Neurocognitive Test Scores.  Table 9 presents data from the 2 groups on 
neurocognitive feigning tests.  It should be noted that lower scores on these tests suggest 
malingering.  Scores on all of these indicators were significantly lower for those in the 
PM group.  Effect sizes ranged from d = -1.01 (for VSVT Difficult) to d = -1.25 (for the 
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LMT), meaning that there was a large difference between the PM and PH groups on tests 
of neurocognitive malingering.  These results suggest that these psychiatric feigners were 
faking neurocognitive definitions as well. 
 MMPI-2 Scores.  Table 10 presents means, standard deviations, t-values, and d 
scores for the MMPI-2 Validity scales.  As expected, the F, Fb, F(p), and F-K scales had 
statistically significantly higher scores in the PM group.  These results indicate that the 
PM group endorsed symptoms that are infrequently reported, even within genuine 
psychiatric populations (e.g. F(p)).  Effect sizes ranged from d =1.23 for F(p) to d = 2.92 
for Fb.  In contrast, the PM group scored lower on the validity scales K and S.  These 
latter two scales are used to detect defensiveness and superiority, and thus expected to be 
lower in groups trying to “fake bad.”  The VRIN, TRIN, and L scales did not show 
statistically significant differences between the PM and PH groups. 
 Table 11 shows that the MMPI-2 Clinical scales were statistically significantly 
higher for those in the PM group compared to the PH group.  This was expected, as the 
PM group would likely be reporting more symptoms of psychopathology than those 
answering honestly.  In addition, it is interesting to note that the PM group was 
emphasizing relatively severe symptoms on scales 6 and 8, which provided the highest 
effect sizes found on the MMPI-2 Clinical scales (d = 2.03 and 1.97, respectively).  
Overall, the effect sizes for the Clinical scales ranged from d = 0.69 (scale 9) to d = 2.03 
(scale 6).   
 M-FAST Scores.  Information on the comparison between the PM and PH groups 
on the M-FAST can be found in Table 12.  All scores were significantly higher for the 
PM group than the PH group.  Effect sizes ranged from d = 0.69 (for the S scale: 
Suggestibility) to d = 4.07 (for the RO scale: Reported vs. Observed symptoms).  The 
Total score showed a very large effect size of d = 3.03.  These analyses suggest that the 
M-FAST effectively discriminates those malingering psychiatric symptoms from those 
shown to be honest in a civil forensic sample.   
Neurocognitive Malingering vs. Honest Groups (NM vs. NH) 
 Moving away from those determined to be malingering on tests of psychiatric 
malingering, the next set of analyses addresses those individuals determined to be 
feigning or honest on tests of neurocognitive malingering.  As previously noted, 
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individuals found to be malingering on at least two of the three tests of neurocognitive 
malingering used in the battery (the TOMM, VSVT, and LMT) were assigned to the 
Neurocognitive Malingering group (NM; n = 75).  Those found to be honest by all three 
of these tests were placed in the Neurocognitive Honest group (NH; n = 178).  Again, any 
participants not meeting either of these criteria were placed in an indeterminate group and 
not used in the following analyses.  As noted earlier, the base rate of neurocognitive 
malingering was 24.4%. 
 Background variables.  Information on age and education for the NM and NH 
groups is presented in Table 13, which shows that no statistically significant differences 
were found.  Likewise, information comparing groups on race, gender, marital status, and 
type of litigation claim is presented in Table 14, and shows no statistically significant 
differences between the two groups.  Again, the 2 groups studied here were comparable 
on these potentially confounding variables. 
 SIRS Scores.  As the SIRS was not part of the criteria for the NM vs. NH groups, 
results are presented in Table 15.  These data show that all SIRS scales were significantly 
higher for the Neurocognitive Malingering group.  Effect sizes ranged from d = 0.49 (for 
the RS scale: Rare Symptoms) to d = 0.99 (for the Total score).  These results suggest 
group differences in psychiatric feigning in patients selected for neurocognitive feigning.  
This finding roughly parallels those in the preceding contrast which showed that 
individuals selected for the present psychiatric feigning group also malingered on tests of 
neurocognitive malingering.   
 MMPI-2 Scores.  The means, standard deviations, t-test results, and d scores for 
the MMPI-2 Validity scales can be found in Table 16.  The Infrequency scales (F, Fb, 
F(p), and F-K) were statistically significantly higher in the NM group, suggesting greater 
psychiatric feigning by the participants.  There were no significant differences found in 
the VRIN, TRIN, L, K, or S scales.  Although these groups were selected based upon 
feigning on neurocognitive malingering tests, these results suggest an increase in 
psychiatric feigning among the NM group, similar to findings on the SIRS. 
 Table 17 shows that for MMPI-2 Clinical scales, all scores were significantly 
higher for the NM group, with the exception of scales 4, 5 and 9.  As was the case with 
the Validity scales, this is interesting in that the participants in the NM group endorsed 
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more psychiatric symptoms although the groups were defined based solely on tests of 
neurocognitive effort.  Effect sizes for the difference between the NM and NH groups 
ranged from d = 0.47 (for scale 1) to d = 1.12 (for scale 8).  Once again, it is interesting 
that scale 8 should have the greatest effect size, which suggests the NM group was 
emphasizing relatively severe psychopathology. 
 M-FAST Scores.  Table 18 shows that all M-FAST scales, with the exception of 
RO (Reported vs. Observed symptoms), USC (Unusual Symptom Course), and S 
(Suggestibility), were significantly higher in the NM group.  The remaining 4 subscales 
and Total score had effect sizes that ranged from moderate at d = 0.64 (for ES: Extreme 
Symptomatology) to large at d = 0.96 (for the Total score).  This is again interesting 
because the M-FAST is specifically designed to screen for psychiatric rather than 
neurocognitive malingering.   
Neurologic Any Malingering vs. Neurologic Both Honest Groups (NAM vs. NBH) 
 As the neurologic group was a significant and interesting subset of the overall 
forensic sample, this subsample was extracted and analyses were run comparing 
malingerers of any symptoms (neurocognitive and/or psychiatric) and honest (on both 
neurocognitive and psychiatric tests) as previously noted.  The base rate of malingering 
for this neurologic subsample was 24.0%.  Unfortunately, further contrasts separating out 
psychiatric and neurocognitive subsets were not possible due to very limited numbers in 
each contrast. 
 Background variables.  Information on age and education for the NAM and NBH 
groups is presented in Table 19, which shows that no statistically significant differences 
were found.  Similarly, information comparing groups on race, gender, marital status, and 
type of litigation claim is presented in Table 20, and likewise shows no statistically 
significant differences between the two groups.  These results show that the NAM and 
NBH groups were comparable on these potentially confounding variables. 
 MMPI-2 Scores.  Means, standard deviations, t-test results, and effect sizes for 
MMPI-2 Validity scale scores for the NAM vs. NBH contrast are presented in Table 21.  
The F, Fb, and F(p) scales were significantly higher for the malingering group, indicating 
that these neurologic malingerers of any kind were reporting infrequently endorsed 
symptoms.  Effect sizes ranged from d = 0.81 (Scale F(p)) to d = 1.33 (Scale Fb).   
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 The MMPI-2 Clinical scale scores were significantly different for all scales with 
the exception of scales 5 and 9, as indicated in Table 22.  This suggests that the 
participants in the NAM group were endorsing a number of severe, even psychotic 
psychiatric symptoms.  Effect sizes ranged from d = 0.71 (Scale 0) to d = 1.41 (Scale 8).   
 M-FAST Scores.  Table 23 shows that the M-FAST Total, UH (Unusual 
Hallucinations), and NI (Negative Impression) scales showed significant differences 
between NAM and NBH groups.  Effect sizes ranged from d = 1.10 (NI: Negative 
Impression) to d = 1.32 (UH: Unusual Hallucinations).  This shows that the M-FAST 
Total score statistically significantly differentiates between neurologic malingering and 
honest groups; however, use of the subscales (with the exception of UH and NI) is not 
supported by these data. 
Synopsis 
 To reiterate, the preceding analyses involved 4 contrasts: Any Malingering vs. 
Both Honest (AM vs. BH), Psychiatric Malingering vs. Psychiatric Honest (PM vs. PH), 
Neurocognitive Malingering vs. Neurocognitive Honest (NM vs. NH), and Neurologic 
Any Malingering vs. Neurologic Both Honest (NAM vs. NBH).  Each pair of groups was 
compared on demographics and other background variables.  No statistically significant 
differences were found between any pair of groups on any of these variables, indicating 
that the malingering and honest groups were comparable on these factors.   
 Honest and malingering participants within each grouping were also compared on 
test performance.  In all cases, significant differences in the expected direction were 
found for most scales.   
 Lastly, the M-FAST Total and subscale scores were compared between honest 
and malingering participants within each grouping.  Effect sizes comparing d-scores 
across the contrasts are presented in Table 24.  For all of the comparisons, the M-FAST 
Total score was significantly higher for the malingering group than the honest using an α 
= 0.01.  The largest effect sizes were found in the PM vs. PH contrast, in which the M-
FAST was solely detecting psychiatric malingering.  Conversely, the lowest effect sizes 
were found in the NM vs. NH contrast, in which participants were feigning 
neurocognitive malingering.  The subscale scores showed variable results, but again were 
strongest in the PM vs. PH group.   
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Incremental Validity of the M-FAST 
 While the above data have shown that the M-FAST is useful in differentiating 
between malingerers and honest responders, the data also show that the MMPI-2 fake bad 
scales also differentiated between these groups.  Therefore, further analyses are suggested 
in order to determine what, if any, increment the M-FAST provides relative to the MMPI-
2 fake-bad scales in detecting feigning.  In order to examine the incremental validity of 
the M-FAST relative to the MMPI-2 fake bad scales, hierarchical logistic regression was 
used.  Two sets of regressions were undertaken for each contrast.  First, MMPI-2 
infrequency scales (F, Fb, F(p)) were made available for conditional, stepwise entry.  
Next, the M-FAST Total score was entered.  In the second set of regressions, the reverse 
order of entry was undertaken. 
Table 25 provides information regarding the incremental validity of the M-FAST 
relative to the MMPI-2 fake bad scales for the AM vs. BH contrast.  In this contrast, the 
F, Fb, and F(p) scales were made available to enter, stepwise and conditionally, followed 
by the M-FAST.  In this first analysis, the MMPI-2 F scale was the only scale to enter the 
equation.  The M-FAST offered no statistically significant incremental validity over the 
MMPI-2 F scale in predicting malingering of psychiatric or neurocognitive symptoms.  
When the reverse analysis was performed, with the M-FAST entered first with the F, Fb, 
and F(p) scales made available to enter, stepwise and conditionally, the MMPI-2 F scale 
did offer statistically significant incremental validity over the M-FAST.  This indicates 
that although the M-FAST predicts group membership in the AM vs. BH contrast, it does 
not predict incremental validity over the MMPI-2. 
Table 26 provides incremental validity information of the M-FAST relative to the 
MMPI-2 fake bad scales for the PM vs. PH comparison. Although F, Fb, and F(p) were 
available to enter stepwise and conditionally, only Fb was a significant predictor.  Next, 
the M-FAST was forced into the equation in a second step.  In this case, the M-FAST did 
add statistically significant incremental validity over the MMPI-2 Fb scale in predicting 
psychiatric malingering.  The converse was also found to be true after forcing in the M-
FAST and making the MMPI-2 F, Fb, and F(p) scales available to enter stepwise and 
conditionally:  the MMPI-2 Fb scale added statistically significant incremental validity 
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over the M-FAST.  This means that although each test accurately predicts group 
membership alone, each instrument adds incremental validity to the other. 
Table 27 provides information regarding the incremental validity of the M-FAST 
Total score relative to the MMPI-2 fake bad scales for the NM vs. NH contrast.  After 
allowing the F, Fb, and F(p) scales to enter stepwise and conditionally, both F and F(p) 
were significant predictors.  Forcing in the M-FAST in the next step, it was found that the 
M-FAST provided no statistically significant incremental validity over the F and F(p) 
scales of the MMPI-2.  Upon running the reverse analysis, with the M-FAST forced in 
first followed by the F, Fb, and F(p) scales available stepwise and conditionally, it was 
found that the MMPI-2 F scale did not add statistically significant incremental validity 
over the M-FAST.   Thus, in the NM vs. NH contrast, each test predicted group 
membership by itself, but neither instrument provided any incremental validity over the 
other.   
Finally, Table 28 evaluates incremental validity information of the M-FAST and 
the MMPI-2 fake bad scales for the NAM vs. NBH comparison.  Similar to the last 
comparison, neither the M-FAST nor the MMPI-2 F scale provided incremental validity 
over the other. 
Synopsis of Incremental Validity 
The above information suggests that the M-FAST provides significant 
incremental validity above and beyond use of the MMPI-2 alone only when identifying 
psychiatric malingering, as can be seen from the PM vs. PH contrast.  However, the M-
FAST provided no increment over the MMPI-2 once neurocognitive malingering was 
involved in any way, as can be seen from the AM vs. BH, NM vs. NH, and NAM vs. 
NBH contrasts.  This indicates that the M-FAST does indeed predict group membership, 
but does not provide incremental validity over the MMPI-2 for malingered 
neurocognitive deficit.   
Operating Characteristics of the M-FAST 
 Cut scores for the M-FAST were compared using ROC curves, sensitivity, 
specificity, positive predictive power (PPP), and negative predictive power (NPP) in 
order to identify the optimal cut score for each contrast (defined here as the highest 
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overall hit rate).  Additionally, the utility of the recommended cutting score of 6 was 
examined.   
Operating characteristics at various cut scores for the AM vs. BH contrast can be 
found in Table 29.  Using an ROC curve, the area under the curve (AUC) was found to be 
0.746.  Again, using information from the ROC curve and the recommended cutting score 
of 6 for the M-FAST Total, Sensitivity was found to be 0.464, Specificity was 0.926, PPP 
was 0.7050, and NPP was 0.8192.  Recall that for the purposes of a screening measure 
such as the M-FAST, NPP and Sensitivity are the main focus.  Although NPP is 
moderately high here, this value combined with the lower Sensitivity value is probably 
unacceptable for screening use.  The hit rate that was the best for screening purposes in 
this contrast was an M-FAST Total score of 4.  This cutting score brought Sensitivity up 
to a value of  0.667 and NPP up to 0.8620, without excessive detriment to Specificity 
(0.793) and PPP (0.5512).  Although these values are acceptable for screening purposes, 
a cutting score of 4 is well below that of the recommended cut score of 6. 
Table 30 presents information about the operating characteristics of the M-FAST 
Total score for the PM vs. PH groups.  Again using the ROC curve, the AUC was found 
to be 0.926, an excellent value considering the highest AUC curve attainable is 1.00.  The 
recommended cutting score of 6 on the M-FAST Total faired very well, yielding a 
Sensitivity of 0.826, Specificity of 0.906, PPP of 0.4161, and NPP of 0.9847.  Again 
drawing attention to the NPP and Sensitivity values, it can be seen that the M-FAST 
performs exceptionally well at this cut score in ruling out honest patients in this contrast.  
These values strongly support the use of the M-FAST for screening purposes if only 
psychiatric feigning is considered.  Additionally, the recommended cut score of 6 seems 
to be adequate for differentiating between the PM and PH groups. 
Table 31 presents information regarding the operating characteristics at various 
cutting scores of the M-FAST for the NM vs. NH contrast.  This contrast yielded less 
promising results, with an AUC value of 0.705, similar to the value found in the AM vs. 
AH contrast.  The recommended cutting score of 6 did not appear to perform as well in 
detecting neurocognitive malingering as it did in detecting psychiatric malingering.  
Sensitivity in this NM vs. NH contrast was found to be 0.432, Specificity was 0.876, PPP 
was 0.5293, and NPP was 0.8216.  These values are not promising for the intended 
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purposes of the M-FAST.  In order to obtain more acceptable operating characteristics, a 
lower cutting score must be evaluated.  Therefore, it appears that a Total score of 3 
provides better Sensitivity (0.757) and NPP (0.8644), without excessive detriment to 
Specificity (0.876) and PPP (0.5293).  
Information regarding the operating characteristics for the NAM vs. NBH contrast 
is provided in Table 32.  The AUC for this contrast was found to be 0.741, which is 
almost identical to the AM vs. BH contrast.  Based upon this, it does not seem as though 
neurological disease alone had any sort of effect on the operating characteristics of the 
M-FAST in detecting a combination of psychiatric and neurocognitive feigning.  Using 
the recommended cut score of 6, Sensitivity was 0.400, Specificity was 0.958, PPP was 
0.7505, and NPP was 0.8349.  Again, for the screening purposes of the M-FAST, the 
focus should be on the NPP and Sensitivity.  Although the NPP is moderately high, 
Sensitivity this low is unacceptable.  Therefore, looking to a lower Total cut score of 3 
may provide the best Sensitivity (0.640) and NPP (0.8616) without significantly 
detracting from Specificity (0.708) and PPP (0.4090).  Again, this is similar to the NM 
vs. NH and AM vs. BH contrasts. 
Synopsis of Operating Characteristics 
 In summary, using the recommended cutting score of 6, the M-FAST performed 
very well in the PM vs. PH contrast.  In this contrast, the M-FAST had excellent 
operating characteristics, especially NPP and Sensitivity which are most important for 
screening purposes.  The results in the other contrasts (AM vs. BH, NM vs. NH, and 
NAM vs. NBH) were not promising, indicating that the M-FAST should not be used to 
detect malingering involving neurocognitive feigning in a civil forensic or neurologic 
sample.  The M-FAST should be used to screen only for psychiatric feigning within this 
type of sample. 
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Table 1   
Group Ns and Malingering Base Rates for Four Contrasts 
    
Type of Malingering M† H† I† Base Rate
  
Any 85 121 102 27.6%*
Psychiatric 23 172 113 7.5%*
Neurocognitive 75 178 55 24.4%*
Neurologic Any 25 48 31 24.0%**
  
     
 
†M = Malingering, H = Honest, I = Indeterminate 
* N = 308 
**N = 104 
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Table 2          
Group Comparisons of Continuous Background Variables 
    Any Malingering vs. Honest (AM vs. BH)      
          
 Any Both  
 Malingering Group† Honest Group†  
    
 N M SD N M SD t df d 
    
Age 85 39.95 10.930 121 42.95 12.702 -1.764 204 -0.25
Education level 85 11.65 2.667 120 12.47 2.722 -2.142 203 -0.30
 
†NMal = 85, NHon = 121, NM+H = 206 
* p < .01   
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Table 3        
Group Comparisons of Discrete Background Variables   
    Any Malingering vs. Honest (AM vs. BH)     
        
  Any Both   
  Malingering† Honest†   
  
  N % N % χ2 df 
  
Demographics  
  
    Race White
Af-Am
Other
79
6
0
92.9%
7.1%
0.0%
111
9
1
91.7%
7.4%
0.8%
0.720 2
    Gender Male 
Female
60
25
70.6%
29.4%
84
37
69.4%
30.6%
0.032 1
    Marital status Single 
Married 
Separated 
Divorced 
Widowed
12
52
1
17
3
14.1%
61.2%
1.2%
20.0%
3.5%
17
78
2
19
2
14.0%
64.5%
1.7%
15.7%
1.7%
1.378 4
Claim Type  
    Pain Yes 36 42.4% 48 39.7% 0.129 1
    Psychiatric Yes 73 85.9% 88 72.7% 4.648 1
    Brain damage Yes 27 31.8% 49 40.5% 1.635 1
    Physical Yes 30 35.3% 29 24.0% 3.006 1
    Medical Yes 7 8.2% 5 4.1% 1.495 1
        
†NMal = 85, NHon = 121, NM+H = 206      
* p < .01  
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Table 4    
Group Comparisons of MMPI-2 Validity Scale Scores     
    Any Malingering vs. Honest (AM vs. BH)   
          
 Any Both    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
MMPI-2    
    
    VRIN 84 50.37 9.551 118 51.19 8.321 -0.639 163.133 -0.09
    TRIN 85 58.28 7.179 118 58.31 8.299 -0.028 201 0.00
    L 85 56.44 9.588 118 57.60 10.454 -0.812 201 -0.11
    K 85 42.28 10.189 118 47.58 10.876 -3.518* 201 -0.50
    S 85 42.80 11.132 118 47.64 10.385 -3.176* 201 -0.45
    F 85 80.66 19.013 118 55.97 13.530 10.246* 142.816 1.59
    Fb 85 90.56 23.537 118 60.09 17.242 10.136* 145.844 1.53
    F(p) 85 58.27 13.018 118 50.21 10.189 4.754* 153.088 0.71
    F – K 85 2.25 8.956 118 -6.94 11.038 6.310* 200 0.90
          
†NMal = 85, NHon = 121, NM+H = 206 
* p < .01 
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Table 5    
Group Comparisons of MMPI-2 Clinical Scale Scores     
    Any Malingering vs. Honest (AM vs. BH)    
          
 Any Both    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
MMPI-2    
    
    1 84 87.68 10.009 118 75.75 12.694 7.456* 197.864 1.03
    2 84 92.70 11.611 118 76.58 14.102 8.886* 195.728 1.23
    3 84 86.68 12.582 118 75.97 16.311 5.265* 198.670 0.73
    4 84 75.10 80.412 118 57.62 10.209 2.337 200 0.44
    5 84 49.55 7.872 118 46.97 8.605 2.176 200 0.31
    6 84 75.29 20.091 118 57.12 14.517 7.076* 142.225 1.08
    7 84 88.14 14.328 118 70.25 13.135 9.185* 200 1.31
    8 84 87.80 17.970 118 64.24 14.840 10.180* 200 1.46
    9 84 50.21 10.803 118 48.05 11.209 1.372 200 0.20
    0 84 74.05 11.789 118 61.41 12.493 7.255* 200 1.04
          
†NMal = 85, NHon = 121, NM+H = 206 
* p < .01 
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Table 6 
Group Comparisons of M-FAST Total and Subscale Scores 
    Any Malingering vs. Honest (AM vs. BH) 
        
 Any Both    
 Malingering† Honest†    
          
 N M SD N M SD        t       df    d 
    
M-FAST    
    
    Total 84 5.74 3.634 121 2.19 1.903 8.201* 114.734 1.36
    RO 84 0.75 0.726 121 0.50 0.565 2.605 149.133 0.40
    ES 84 1.42 0.853 121 0.77 0.692 5.987* 203 0.86
    RC 84 1.42 1.562 121 0.28 0.595 6.353* 99.856 1.15
    UH 84 0.93 0.929 121 0.21 0.432 6.568* 108.146 1.13
    USC 84 0.35 0.478 121 0.13 0.340 3.511* 139.611 0.55
    NI 84 0.69 0.465 121 0.21 0.412 7.538* 164.465 1.11
    S 85 0.20 0.404 121 0.05 0.253 3.071* 127.873 0.48
          
†NMal = 85, NHon = 121, NM+H = 206 
* p < .01  
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Table 7          
Group Comparisons of Continuous Background Variables 
    Psychiatric Malingering vs. Honest (PM vs. PH)      
          
 Psychiatric Psychiatric  
 Malingering Group† Honest Group†  
   
 N M SD N M SD t df d 
   
Age 23 39.04 9.777 172 42.92 12.096 -1.475 193 -0.33
Education level 23 11.78 1.536 171 12.2.7 2.724 -0.837 192 -0.19
          
†NMal = 23, NHon = 172, NM+H = 195 
* p < .01   
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Table 8        
Group Comparisons of Discrete Background Variables   
    Psychiatric Malingering vs. Honest (PM vs. PH)    
        
  Psychiatric Psychiatric   
  Malingering† Honest†   
  
  N % N % χ2 df 
  
Demographics  
  
    Race White
Af-Am
Other
23
0
0
100.0%
0.0%
0.0%
157
14
1
91.3%
8.1%
0.6%
2.173 
 
2
    Gender Male 
Female
15
8
65.2%
34.8%
122
49
70.9%
28.5%
0.367 1
    Marital status Single 
Married 
Separated 
Divorced 
Widowed
5
12
0
6
0
21.7%
52.2%
0.0%
26.1%
0.0%
20
116
2
26
4
11.6%
67.4%
1.2%
15.1%
2.3%
4.535 4
Claim Types  
    Pain Yes 5 21.7% 70 40.7% 2.921 1
    Psychiatric Yes 22 95.7% 124 72.1% 5.672 1
    Brain damage Yes 5 21.7% 72 41.9% 3.437 1
    Physical Yes 7 30.4% 40 23.3% 0.501 1
    Medical Yes 1 4.3% 6 3.5% 0.041 1
      
†NMal = 23, NHon = 172, NM+H = 195      
* p < .01  
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Table 9    
Group Comparisons of Neurocognitive Test Scores     
    Psychiatric Malingering vs. Honest (PM vs. PH)     
          
 Psychiatric Psychiatric    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
TOMM 
 
    Trial 2 
 
 
23 
 
 
84.26 20.166 172 96.53 9.718 -2.875* 23.385 -1.12
    
VSVT    
    Diff 23 61.91 29.985 172 84.34 21.170 -3.474* 25.016 -1.01
    Total 23 76.52 19.730 172 91.29 12.576 -3.496* 24.446 -1.10
LMT 23 79.53 22.980 172 94.99 11.044 -3.178* 23.377 -1.25
          
†NMal = 23, NHon = 172, NM+H = 195 
* p < .01 
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Table 10    
Group Comparisons of MMPI-2 Validity Scale Scores     
    Psychiatric Malingering vs. Honest (PM vs. PH)     
          
 Psychiatric Psychiatric    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
MMPI-2    
    
    VRIN 23 48.30 8.314 169 51.46 8.761 -1.628 190 -0.36
    TRIN 23 58.39 7.578 169 58.78 8.126 -0.217 190 -0.05
    L 23 55.17 8.600 169 58.76 10.606 -1.554 190 -0.35
    K 23 38.17 7.414 169 48.01 11.082 -5.569* 36.964 -0.92
    S 23 36.52 10.655 169 48.36 10.827 -4.929* 190 -1.10
    F 23 96.17 15.305 169 58.21 13.868 12.164* 190 2.70
    Fb 23 111.65 11.578 169 61.90 17.722 17.945* 37.763 2.92
    F(p) 23 64.74 13.676 169 50.60 11.209 5.523* 190 1.23
    F – K 23 8.61 7.334 168 -6.57 10.171 6.909* 189 1.54
          
†NMal = 23, NHon = 172, NM+H = 195 
* p < .01 
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Table 11    
Group Comparisons of MMPI-2 Clinical Scale Scores     
    Psychiatric Malingering vs. Honest (PM vs. PH)     
          
 Psychiatric Psychiatric    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
MMPI-2    
    
    1 22 92.86 7.376 168 77.66 12.580 8.227* 39.326 1.27
    2 22 96.86 8.317 168 78.81 14.535 8.605* 40.345 1.30
    3 22 90.55 9.231 168 77.48 15.700 5.655* 39.216 0.87
    4 22 73.23 7.746 168 58.54 10.112 6.559* 188 1.49
    5 22 51.32 7.473 168 46.76 8.365 2.430 188 0.55
    6 22 88.91 17.979 168 57.87 14.965 8.930* 188 2.03
    7 22 96.32 5.677 168 72.22 14.511 14.616* 66.214 1.78
    8 22 97.95 20.151 168 66.71 15.362 8.630* 188 1.97
    9 22 54.41 6.478 168 47.31 10.776 3.015* 188 0.69
    0 22 77.23 9.995 168 62.80 13.088 6.119* 31.291 1.13
          
†NMal = 23, NHon = 172, NM+H = 195 
* p < .01 
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Table 12 
Group Comparisons of M-FAST Total and Subscale Scores 
    Psychiatric Malingering vs. Honest (PM vs. PH) 
        
 Psychiatric Psychiatric    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t      df    d 
    
M-FAST    
    
    Total 23 9.04 3.111 172 2.39 2.073 9.960* 24.695 3.03
    RO 23 1.09 0.793 172 0.567 0.043 4.228* 192 4.07
    ES 23 2.04 1.065 172 0.80 0.665 5.453* 24.361 1.75
    RC 23 2.61 1.644 172 0.31 0.671 6.631* 22.996 2.94
    UH 23 1.48 0.846 172 0.27 0.518 6.690* 24.268 2.18
    USC 23 0.61 0.499 172 0.15 0.354 4.301* 25.070 1.24
    NI 23 0.96 0.209 172 0.26 0.442 12.594* 54.014 1.68
    S 23 0.26 0.449 172 0.06 0.269 2.051* 24.167 0.69
          
†NMal = 23, NHon = 172, NM+H = 195 
* p < .01  
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Table 13          
Group Comparisons of Continuous Background Variables 
    Neurocognitive Malingering vs. Honest (NM vs. NH)     
          
 Neurocognitive Neurocognitive  
 Malingering Group† Honest Group†  
   
 N M SD N M SD t df d 
   
Age 75 40.57 10.940 178 41.88 11.768 -0.821 251 -0.11
Education level 75 11.68 2.786 177 12.33 2.548 -1.794 250 -0.25
          
†NMal = 75, NHon = 178, NM+H = 253 
* p < .01   
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Table 14         
Group Comparisons of Discrete Background Variables    
    Neurocognitive Malingering vs. Honest (NM vs. NH)     
         
  Neurocognitive Neurocognitive    
  Malingering† Honest†    
   
  N % N % χ2 df d 
   
Demographics   
   
    Race White
Af-Am
Other
69
6
0
92.0%
8.0%
0.0%
164
13
1
92.1% 
7.3% 
0.6% 
0.456 2
    Gender Male 
Female
52
23
69.3%
30.7%
118
60
66.3% 
33.7% 
0.221 1
    Marital status Single 
Married 
Separated 
Divorced 
Widowed
9
48
1
14
3
12.0%
64.0%
1.3%
18.7%
4.0%
22
119
4
28
2
12.6% 
68.0% 
2.3% 
15.7% 
1.1% 
2.743 4
Claim Types   
    Pain Yes 34 45.3% 72 40.4% 0.442 1
    Psychiatric Yes 64 85.3% 138 78.0% 1.798 1
    Brain damage Yes 24 32.0% 62 35.0% 0.215 1
    Physical Yes 27 36.0% 43 24.2% 3.499 1
    Medical Yes 7 9.3% 6 3.4% 3.803 1
         
†NMal = 75, NHon = 178, NM+H = 253 
* p < .01  
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Table 15    
Group Comparisons of SIRS Scores     
    Neurocognitive Malingering vs. Honest (NM vs. NH)     
          
 Neurocognitive Neurocognitive    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
SIRS    
    
    Total 75 43.03 26.113 178 22.91 18.035 6.088* 104.962 0.99
    RS 75 1.33 2.226 178 0.59 1.233 2.722* 93.713 0.49
    SC 75 1.47 1.671 178 0.60 1.086 4.133* 101.326 0.69
    IA 75 0.96 1.144 178 0.38 0.850 3.979* 109.901 0.62
    BL 75 4.35 4.397 178 2.02 2.751 4.241* 99.296 0.72
    SU 75 13.45 7.600 178 7.70 5.812 5.870* 112.115 0.91
    SEL 75 11.83 5.463 178 7.38 4.773 6.475* 251 0.89
   SEV 75 6.09 6.047 178 2.38 3.910 4.908* 101.051 0.82
    RO 75 3.55 2.637 178 1.86 1.892 5.023* 107.463 0.80
          
†NMal = 75, NHon = 178, NM+H = 253 
* p < .01 
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Table 16    
Group Comparisons of MMPI-2 Validity Scale Scores     
    Neurocognitive Malingering vs. Honest (NM vs. NH)     
          
 Neurocognitive Neurocognitive    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
MMPI-2    
    
    VRIN 74 50.82 9.772 173 52.07 8.598 -1.000 245 -0.14
    TRIN 75 58.29 6.976 173 57.76 8.666 0.468 246 0.06
    L 75 56.84 9.744 173 56.79 10.922 0.033 246 0.00
    K 75 43.04 10.427 173 45.86 10.596 -1.935 246 -0.27
    S 75 43.95 10.438 173 45.48 10.753 -1.040 246 -0.14
    F 75 78.99 18.753 173 59.47 16.095 7.845* 123.400 1.16
    Fb 75 88.08 23.595 173 66.95 22.155 6.764* 246 0.94
    F(p) 75 57.47 12.341 173 50.71 11.789 4.086* 246 0.57
    F – K 75 1.49 8.880 172 -5.25 10.580 4.827* 245 0.67
          
†NMal = 75, NHon = 178, NM+H = 253 
* p < .01 
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Table 17    
Group Comparisons of MMPI-2 Clinical Scale Scores     
    Neurocognitive Malingering vs. Honest (NM vs. NH)     
          
 Neurocognitive Neurocognitive    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
MMPI-2    
    
    1 75 86.83 9.964 172 77.50 13.425 6.056* 186.860 0.47
    2 75 91.91 11.838 172 80.31 15.509 6.414* 182.084 0.81
    3 75 86.53 12.989 172 77.05 16.353 4.864* 175.387 0.62
    4 75 75.20 85.112 172 59.75 11.069 2.342 245 0.46
    5 75 49.36 8.112 172 48.40 9.354 0.770 245 0.11
    6 75 72.97 19.674 172 61.45 16.489 4.754* 245 0.66
    7 75 86.92 14.665 172 73.92 14.499 6.458* 245 0.89
    8 75 87.27 16.076 172 68.38 17.306 8.056* 245 1.12
    9 75 49.75 11.064 172 48.99 10.737 0.502 245 0.07
    0 75 73.19 12.029 171 63.58 12.544 5.595* 244 0.78
          
†NMal = 75, NHon = 178, NM+H = 253 
* p < .01 
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Table 18 
Group Comparisons of MFAST Total and Subscale Scores 
    Neurocognitive Malingering vs. Honest (NM vs. NH) 
        
 Neurocognitive Neurocognitive    
 Malingering† Honest†    
          
 N M SD N M SD       t  df    d 
    
M-FAST    
    
    Total 74 5.49 3.698 178 2.86 2.338 5.658* 98.153 0.96
    RO 74 0.68 0.704 178 0.61 0.640 0.756 250 0.11
    ES 74 1.38 0.823 178 0.90 0.726 4.533* 250 0.64
    RC 74 1.30 1.515 178 0.40 0.791 4.805* 90.037 0.90
    UH 74 0.95 0.978 178 0.34 0.543 4.997* 92.260 0.91
    USC 74 0.34 0.476 178 0.17 0.380 2.629 113.554 0.42
    NI 74 0.66 0.476 178 0.34 0.476 4.852* 250 0.67
    S 74 0.20 0.405 177 0.07 0.274 2.627 102.036 0.42
          
†NMal = 75, NHon = 178, NM+H = 253 
* p < .01  
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Table 19          
Group Comparisons of Continuous Background Variables 
Neurologic Any Malingering vs. Honest (NAM vs. NBH)    
          
 Neurologic Neurologic  
 Any Any  
 Malingering Group† Honest Group†  
   
 N M SD N M SD t df d 
   
Age 25 35.72 12.287 48 42.35 15.758 -1.833 71 0.45
Education level 25 12.76 1.877 48 13.15 3.073 -0.573 71 0.15
          
†NMal = 25, NHon = 48, NM+H = 73 
* p < .01   
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Table 20        
Group Comparisons of Discrete Background Variables   
Neurologic Any Malingering vs. Honest (NAM vs. NBH)   
        
  Neurologic Neurologic   
  Any Any   
  Malingering† Honest†   
  
  N % N % χ2 Df 
  
Demographics  
  
    Race White
Af-Am
Other
25
0
0
100.0%
0.0%
0.0%
47
0
1
97.9%
0.0%
2.1%
 2
    Gender Male 
Female
14
11
56.0%
0.0%
34
14
70.8% 
0.0% 
0.360 1
    Marital status Single 
Married 
Separated 
Divorced 
Widowed
9
10
0
6
0
36.0% 
40.0% 
0.0% 
24.0% 
0.0% 
12
27
0
7
1
25.5%
57.4%
0.0%
14.9%
2.1%
1.040 4
Claim Types  
    Pain Yes 3 12.0% 3 6.3% 14.440 1
    Brain damage Yes 25 100.0% 48 100.0%  1
    Physical Yes 1 4.0% 2 4.2% 21.160 1
    Medical Yes 1 4.0% 1 2.1% 21.160 1
      
†NMal = 23, NHon = 172, NM+H = 195      
* p < .01  
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Table 21    
Group Comparisons of MMPI-2 Validity Scale Scores     
Neurologic Any Malingering vs. Honest (NAM vs. NBH)     
          
 Neurologic Neurologic    
 Any Any    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
MMPI-2    
    
    VRIN 25 48.88 8.467 47 52.09 8.802 -1.490 70 0.37
    TRIN 25 58.60 8.347 47 59.47 10.166 -0.366 70 0.09
    L 25 56.80 10.508 47 56.40 11.371 0.144 70 0.04
    K 25 44.16 13.111 47 46.64 10.044 -0.825 39.325 0.22
    S 25 46.04 12.811 47 47.23 9.421 -0.411 38.145 0.11
    F 25 74.68 16.532 47 55.15 14.345 5.215* 70 1.29
    Fb 25 83.88 27.002 47 56.36 17.380 4.613* 34.860 1.33
    F(p) 25 57.56 11.321 47 49.11 10.031 3.255* 70 0.81
    F – K 25 -0.20 9.713 47 -5.40 14.015 1.655 70 0.41
          
†NMal = 25, NHon = 47, NM+H = 72 
* p < .01 
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Table 22    
Group Comparisons of MMPI-2 Clinical Scale Scores     
Neurologic Any Malingering vs. Honest (NAM vs. NBH)     
          
 Neurologic Neurologic    
 Any Any    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t df d 
    
MMPI-2    
    
    1 24 84.25 11.399 47 74.19 12.199 3.358* 69 0.84
    2 24 87.13 15.793 47 73.30 13.899 3.787* 69 0.95
    3 24 84.33 14.942 47 72.04 14.942 3.279* 69 0.82
    4 24 63.50 7.824 47 54.98 9.896 3.669* 69 0.93
    5 24 50.08 7.807 47 47.28 9.221 1.275 69 0.32
    6 24 70.92 16.245 47 55.26 14.030 4.216* 69 1.06
    7 24 83.38 16.849 47 67.68 12.116 4.509* 69 1.14
    8 24 84.25 15.422 47 62.74 15.179 5.617* 69 1.41
    9 24 52.79 13.048 47 46.74 12.234 1.926 69 0.48
    0 24 69.75 14.087 47 61.23 10.979 2.804* 69 0.71
          
†NMal = 24, NHon = 47, NM+H = 71 
* p < .01 
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Table 23 
Group Comparisons of M-FAST Total and Subscale Scores 
    Neurologic Any Malingering vs. Honest (NAM vs. NBH) 
        
 Neurologic Neurologic    
 Any Any    
 Malingering Group† Honest Group†    
          
 N M SD N M SD       t      df    d 
    
M-FAST    
    
    Total 25 4.52 3.607 48 1.73 1.484 3.709* 28.305 1.26
    RO 25 0.76 0.779 48 0.48 0.505 1.633 34.801 0.47
    ES 25 1.04 0.735 48 0.63 0.640 2.498 71 0.61
    RC 25 1.04 1.485 48 0.21 0.459 2.732 26.416 1.03
    UH 25 0.72 0.891 48 0.08 0.279 3.486* 26.486 1.32
    USC 25 0.28 0.458 48 0.17 0.377 1.064 41.250 0.27
    NI 25 0.56 0.507 48 0.13 0.334 3.876* 35.190 1.10
    S 25 0.12 0.332 48 0.04 0.202 1.081 33.525 0.33
          
†NMal = 25, NHon = 48, NM+H = 73 
* p < .01  
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Table 24 
Effect Sizes of the M-FAST Total Scores Across Contrasts 
 
M-FAST AM vs. BM PM vs. PH NM vs. NH NAM vs. NBH 
d-Scores     
     
  Total 1.36* 3.03* 0.96* 1.26* 
  RO 0.40 4.07* 0.11 0.47 
  ES 0.86* 1.75* 0.64* 0.61 
  RC 1.15* 2.94* 0.90* 1.03 
  UH 1.13* 2.18* 0.91* 1.32* 
  USC 0.55* 1.24* 0.42 0.27 
  NI 1.11* 1.68* 0.67* 1.10* 
  S 0.48* 0.69* 0.42 0.33 
*p<0.01
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Table 25 
Hierarchical Logistical Regression Results for AM vs. BH 
________________________________________________________________________ 
Step                       χ2                 Δχ2                 R2                  ΔR2           % correctly predicted 
1 F 1   72.004* 72.004* 0.483  0.483  82.0% 
   
2 M-FAST2     81.843* 4.647  0.534  0.051  82.0% 
 
1 M-FAST2  63.573* 63.573* 0.437  0.437  77.6% 
 
2 F 1  80.957* 17.384* 0.529  0.092  82.0% 
 
 
1 MMPI-2 scales entered stepwise in this block: F, Fb, F(p). 2 M-FAST Total scale 
entered in this block. 
Note. R2 = Nagelkerke R2.  
*p < 0.01 
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Table 26 
Hierarchical Logistical Regression Results for PM vs. PH 
________________________________________________________________________ 
Step                       χ2                 Δχ2                 R2                  ΔR2           % correctly predicted 
1 Fb 1   84.983* 84.983* 0.797  0.797  93.3% 
 
2 M-FAST2     92.569*    7.586*  0.848  0.051            97.3%       
 
1 M-FAST2  76.791* 76.791* 0.738  0.738  96.0% 
 
2 Fb 1   92.569* 15.778* 0.848  0.110  97.3% 
 
 
1 MMPI-2 scales entered in this step: F, Fb, F(p). 2 M-FAST Total scale entered in this 
step. 
Note. R2 = Nagelkerke R2.  
*p < 0.01 
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Table 27 
Hierarchical Logistical Regression Results for NM vs. NH 
________________________________________________________________________ 
Step                       χ2                 Δχ2                 R2                  ΔR2           % correctly predicted 
1 F 1   27.727* 27.727* 0.181  0.181  74.3% 
  
1 F(p) 1 9.475*  37.202* 0.237  0.056  72.8% 
   
2 M-FAST2     43.878* 6.676  0.276  0.039  77.2% 
 
1 M-FAST2  34.159* 34.159* 0.220  0.220  75.2% 
 
2 F 1  38.762* 4.602  0.246  0.026  77.7% 
 
 
1 MMPI-2 scales entered in this step: F, Fb, F(p). 2 M-FAST Total scale entered in this 
step. 
Note. R2 = Nagelkerke R2.  
*p < 0.01 
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Table 28 
Hierarchical Logistical Regression Results for NAM vs. NBH 
________________________________________________________________________ 
Step                       χ2                 Δχ2                 R2                  ΔR2           % correctly predicted 
1 F 1   18.170* 18.170* 0.366  0.366  81.0% 
   
2 M-FAST2     21.109* 2.939  0.415  0.049  77.6% 
 
1 M-FAST2  14.460* 14.460* 0.300  0.300  75.9% 
 
2 F 1  21.109* 6.649  0.415  0.115  77.6% 
 
1 MMPI-2 scales entered stepwise in this block: F, Fb, F(p). 2 M-FAST Total scale 
entered in this block. 
Note. R2 = Nagelkerke R2.  
*p < 0.01 
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Table 29      
Test Characteristics of  the M-FAST 
Any Malingering vs. Both Honest (AM vs. BH)* 
      
Total M-FAST Cut Score Sensitivity Specificity PPP NPP Hit Rate 
1 0.964 0.157 0.3036 0.9196 0.3797 
2 0.905 0.471 0.3947 0.9286 0.5908 
3 0.786 0.628 0.4461 0.8850 0.6716 
4 0.667 0.793 0.5512 0.8620 0.7582 
5 0.583 0.893 0.6750 0.8489 0.8074 
6 0.464 0.926 0.7050 0.8192 0.7985 
7 0.381 0.975 0.8532 0.8051 0.8111 
8 0.310 0.983 0.8742 0.7889 0.7973 
9 0.226 0.992 0.9150 0.7707 0.7806 
10 0.143 0.992 0.8720 0.7523 0.7577 
11 0.119 1.000 1.0000 0.7486 0.7568 
12 0.095 1.000 1.0000 0.7435 0.7502 
13 0.048 1.000 1.0000 0.7337 0.7372 
14 0.036 1.000 1.0000 0.7313 0.7339 
15 0.012 1.000 1.0000 0.7264 0.7273 
16 0.000 1.000 1.0000 0.7240 0.7240 
17 0.000 1.000 1.0000 0.7240 0.7240 
18 0.000 1.000 1.0000 0.7240 0.7240 
19 0.000 1.000 1.0000 0.7240 0.7240 
20 0.000 1.000 1.0000 0.7240 0.7240 
21 0.000 1.000 1.0000 0.7240 0.7240 
22 0.000 1.000 1.0000 0.7240 0.7240 
23 0.000 1.000 1.0000 0.7240 0.7240 
24 0.000 1.000 1.0000 0.7240 0.7240 
25 0.000 1.000 1.0000 0.7240 0.7240 
*Base Rate = 27.6% 
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Table 30      
Test Characteristics of  the M-FAST 
Psychiatric Malingering vs. Psychiatric Honest (PM vs. PH)* 
      
Total M-FAST Cut Score Sensitivity Specificity PPP NPP Hit Rate 
1 1.000 0.152 0.0873 1.000 0.2156 
2 1.000 0.427 0.1240 1.000 0.4700 
3 1.000 0.596 0.1671 1.000 0.6263 
4 0.957 0.766 0.2490 0.9955 0.7803 
5 0.957 0.854 0.3470 0.9959 0.8617 
6 0.826 0.906 0.4161 0.9847 0.9000 
7 0.826 0.959 0.6203 0.9855 0.9490 
8 0.739 0.977 0.7226 0.9788 0.9592 
9 0.565 0.988 0.7924 0.9655 0.9563 
10 0.348 0.988 0.7016 0.9492 0.9400 
11 0.261 0.994 0.7791 0.9431 0.9390 
12 0.217 1.000 1.000 0.9403 0.9413 
13 0.174 1.000 1.000 0.9372 0.9381 
14 0.130 1.000 1.000 0.9341 0.9348 
15 0.043 1.000 1.000 0.9280 0.9282 
16 0.000 1.000 1.000 0.9250 0.9250 
17 0.000 1.000 1.000 0.9250 0.9250 
18 0.000 1.000 1.000 0.9250 0.9250 
19 0.000 1.000 1.000 0.9250 0.9250 
20 0.000 1.000 1.000 0.9250 0.9250 
21 0.000 1.000 1.000 0.9250 0.9250 
22 0.000 1.000 1.000 0.9250 0.9250 
23 0.000 1.000 1.000 0.9250 0.9250 
24 0.000 1.000 1.000 0.9250 0.9250 
25 0.000 1.000 1.000 0.9250 0.9250 
*Base Rate = 7.5% 
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Table 31      
Test Characteristics of  the M-FAST 
Neurocognitive Malingering vs. Neurocognitive Honest (NM vs. NH)* 
      
Total M-FAST Cut Score Sensitivity Specificity PPP NPP Hit Rate 
1 0.959 0.124 0.2611 0.9036 0.3277 
2 0.892 0.348 0.3063 0.9090 0.4807 
3 0.757 0.500 0.3282 0.8644 0.5627 
4 0.635 0.685 0.3942 0.8533 0.6728 
5 0.541 0.798 0.4636 0.8434 0.7353 
6 0.432 0.876 0.5293 0.8269 0.7677 
7 0.338 0.927 0.5991 0.8127 0.7833 
8 0.270 0.944 0.6088 0.8003 0.7795 
9 0.189 0.961 0.6100 0.7859 0.7726 
10 0.135 0.983 0.7193 0.7788 0.7761 
11 0.122 0.994 0.8678 0.7782 0.7812 
12 0.108 1.000 1.000 0.7765 0.7824 
13 0.054 1.000 1.000 0.7661 0.7682 
14 0.041 1.000 1.000 0.7636 0.7660 
15 0.014 1.000 1.000 0.7586 0.7594 
16 0.000 1.000 1.000 0.7560 0.7560 
17 0.000 1.000 1.000 0.7560 0.7560 
18 0.000 1.000 1.000 0.7560 0.7560 
19 0.000 1.000 1.000 0.7560 0.7560 
20 0.000 1.000 1.000 0.7560 0.7560 
21 0.000 1.000 1.000 0.7560 0.7560 
22 0.000 1.000 1.000 0.7560 0.7560 
23 0.000 1.000 1.000 0.7560 0.7560 
24 0.000 1.000 1.000 0.7560 0.7560 
25 0.000 1.000 1.000 0.7560 0.7560 
*Base Rate = 24.4% 
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Table 32      
Test Characteristics of  the M-FAST 
Neurologic Any Malingering vs. Neurologic Both Honest (NAM vs. NBH)* 
      
Total M-FAST Cut Score Sensitivity Specificity PPP NPP Hit Rate 
1 0.880 0.187 0.2547 0.8315 0.3533 
2 0.760 0.562 0.3540 0.8812 0.6095 
3 0.640 0.708 0.4090 0.8616 0.6917 
4 0.520 0.896 0.6122 0.8553 0.8058 
5 0.520 0.958 0.7963 0.8634 0.8529 
6 0.400 0.958 0.7505 0.8349 0.8241 
7 0.280 1.000 1.0000 0.8148 0.8272 
8 0.160 1.000 1.0000 0.7903 0.7984 
9 0.120 1.000 1.0000 0.7825 0.7888 
10 0.120 1.000 1.0000 0.7825 0.7888 
11 0.120 1.000 1.0000 0.7825 0.7888 
12 0.040 1.000 1.0000 0.7674 0.7696 
13 0.040 1.000 1.0000 0.7674 0.7696 
14 0.040 1.000 1.0000 0.7674 0.7696 
15 0.040 1.000 1.0000 0.7674 0.7696 
16 0.000 1.000 1.0000 0.7600 0.7600 
17 0.000 1.000 1.0000 0.7600 0.7600 
18 0.000 1.000 1.0000 0.7600 0.7600 
19 0.000 1.000 1.0000 0.7600 0.7600 
20 0.000 1.000 1.0000 0.7600 0.7600 
21 0.000 1.000 1.0000 0.7600 0.7600 
22 0.000 1.000 1.0000 0.7600 0.7600 
23 0.000 1.000 1.0000 0.7600 0.7600 
24 0.000 1.000 1.0000 0.7600 0.7600 
25 0.000 1.000 1.0000 0.7600 0.7600 
*Base Rate = 24.0% 
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Discussion 
 The purpose of this study was to evaluate the utility of the M-FAST a civil 
forensic sample that included neurological patients.  Previous studies of the M-FAST had 
shown it to be effective in samples including inmates and psychiatric inpatients, but none 
had examined a sample that included individuals who were currently in litigation for 
reasons such as workers compensation, personal injury, and disability.  This study 
attempted to assess whether or not the M-FAST would be valid in such a sample. 
 In order to do this, data were taken from individuals referred to a private practice 
neuropsychiatrist for a full battery of neuropsychological testing.  Among the many other 
tests given, assessments included tests of psychiatric malingering (SIRS, M-FAST, & 
MMPI-2), as well as tests of neurocognitive malingering (TOMM, VSVT, & LMT).   
Four sets of contrasts were formed based on these tests: Any Malingering vs. Both 
Honest (AM vs. BH), Psychiatric Malingering vs. Psychiatric Honest (PM vs. PH), 
Neurocognitive Malingering vs. Neurocognitive Honest (NM vs. NH), and Neurologic 
Any Malingering vs. Neurologic Both Honest (NAM vs. NBH).   
The M-FAST Total score was found to differentiate between honest and feigning 
groups in all contrasts, with effect sizes ranging from d = 3.03 (PM vs. PH) to d = 0.96 
(NM vs. NH).  Although all scales on the M-FAST differentiated between groups in the 
PM vs. PH contrast, the subscales did not perform as well when any type of 
neurocognitive malingering was introduced.  The RO subscale did not differentiate in any 
of the other contrasts.  The USC and S subscales did not differentiate between NM vs. 
NH and NAM vs. NBH, whereas ES and RC did not differentiate between NAM and 
NBH.  In essence, although the M-FAST total score performed well, the use of the 
subscales is not well supported. 
Interestingly, although the groups were divided based upon performance on either 
psychiatric or neurocognitive malingering tests for the last two contrasts, it appears that 
some participants feigned global symptoms and typically did not restrict their feigning to 
specifically psychiatric or neurocognitive symptoms.  For example, the PM vs. PH 
contrast showed group differences on select MMPI-2 Validity and Clinical scales, as well 
as the M-FAST, as would be expected given the nature of the groupings.  However, there 
were also statistically significant differences between the PM vs. PH groups on all tests 
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of neurocognitive malingering, indicating that this group was unexpectedly feigning 
neurocognitive symptoms. 
 Similarly, for the NM vs. NH contrast statistically significant group differences 
were found on all SIRS scales, selected MMPI-2 Validity and Clinical scales, as well as 
the M-FAST Total and selected subscales, indicating that this group unexpectedly 
feigned psychiatric symptoms.   
 The AM vs. BH contrast showed statistically significant differences for all 
neurocognitive tests, all SIRS scales, all MMPI-2 Validity scales, select MMPI-2 Clinical 
scales, and all but one of the M-FAST scales.  This again suggests that the participants 
were feigning global symptoms, and did not restrict feigning to solely psychiatric or 
neurocognitive symptoms. 
 The NAM vs. NBH contrast showed similar statistically significant group 
differences on criterion measures and most MMPI-2 scales.  Here the M-FAST faired less 
well, with only the Total score and 2 of the subscales (UH and NI) differentiating 
between the groups. 
 Hierarchical logistic regression analyses showed that the M-FAST provided 
incremental validity over the MMPI-2 Fake Bad scales for the PM vs. PH contrast only.  
The M-FAST provided no incremental validity over any of the other MMPI-2 fake bad 
scales for any of the other contrasts.  This may be due to the fact that the M-FAST was 
designed to detect psychiatric feigning.  A large percentage of the civil forensic 
population consisted of neurologic patients (33.8%), many of which were feigning 
neurocognitive symptoms.  In fact, all of the other contrasts included those feigning 
neurocognitive symptoms.   
Differences across contrasts can also be seen in the operating characteristics of the 
M-FAST.  For the PM vs. PH contrast, the recommended cut score of 6 provided 
adequate Sensitivity and NPP, without decreasing Specificity or PPP to a substantial 
degree.  However, for those contrasts that included neurocognitive feigning, a lower cut 
score provided the best Sensitivity and NPP for screening purposes.  A cutting score of 4 
was best for the AM vs. BH comparison, whereas a cutting score of 3 was best for the 
NM vs. NH and NAM vs. NBH contrasts. 
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 In summary, the M-FAST was able to differentiate between all contrasts within 
this population using the recommended cutting score of 6 (Miller, 2001; Miller, 2004; 
Jackson, Rogers, & Sewell, 2005; Guy & Miller, 2004).  However, only the PM vs. PH 
contrast showed the M-FAST to have similar utility as previous studies.  It is 
recommended, therefore, that the M-FAST only be used in the detection of psychiatric 
malingering.  Other measures such as the LMT, TOMM, and VSVT must be 
implemented in order to detect neurocognitive malingering. 
 These results from the PM vs. PH grouping were similar to those previously 
published.  Miller (2001) originally showed a NPP of 0.97 and a PPP of 0.68 at a cutting 
score of 6 using a sample of forensic psychiatric patients.  Similar findings were 
published by Jackson, Rogers, & Sewell (2005) using forensic inpatients in which PPP 
was 0.91 and NPP was 0.74 at a cutting score of 6.  In addition, Guy & Miller (2004) 
used a sample of incarcerated males in which PPP was 0.89 and NPP was 0.78.  
Moreover, Miller’s (2001) study using a nonclinical college sample highlights the 
disparity even further, with a NPP of 0.94 and PPP of 1.00.  Thus, the present findings 
from the PM vs. PH group are quite consistent with previous work on the M-FAST. 
 A possible reason for the similarity between the PM vs. PH contrast and previous 
literature is that both incarcerated individuals and forensic inpatients are more likely to be 
malingering psychiatric symptoms rather than neurocognitive symptoms.  However, since 
no analyses were done in these previous studies to assess the type of malingering, nothing 
can be said definitively regarding this hypothesis.  It is also likely that within a civil 
forensic population, especially one that includes a large number of neurological patients, 
neurocognitive malingering would be more likely than in previously assessed settings.  
Although the M-FAST recommended cutting score of 6 did not perform well at 
differentiating between honest and malingering groups in the contrasts involving the AM, 
NM, and NAM groups, the presence of neurocognitive feigning in some capacity may 
have contributed to the lower cut scores being best for screening purposes in these 
contrasts. 
 Although this study makes a contribution to cross-validation of the M-FAST, the 
only individuals studied were those who gave permission for their results to be used in 
research.  It may be that there is a qualitative difference between those giving permission 
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and those not.  For instance, perhaps if an individual was knowingly malingering or 
intended on faking on psychological testing, it may be plausible that they would not give 
permission.  In addition, the sample is limited by its demographics, which include an 
overwhelming majority of white, male, married individuals, roughly around the age of 40 
with over 11 years of education.  Although this is typical of the population referred for 
civil forensic psychological assessment in Lexington, KY, the generalizability of the 
sample is quite limited.  Also, it is not known whether such a large number of neurologic 
patients is typical for most forensic practices. 
 Another limitation is the fact that method variance may have operated here.  Since 
both the M-FAST and the SIRS (a criterion used for group membership) were given in 
interview form, it may be that some of the predictive ability of the M-FAST in 
differentiating between SIRS-defined groups is due to similarities in the method in which 
the tests were given. 
 Suggestions for future research include examining the M-FAST in other civil 
forensic samples, particularly in other areas of the country where the demographic 
variables may be more diverse.  In addition, further examination of the utility of the M-
FAST within a neurological sample is recommended.  Although the current sample had a 
large number of neurologic patients, there were unfortunately not enough to examine 
psychiatric only and neurocognitive only contrasts within this group.  It would be 
interesting to examine the utility of the M-FAST with regards to solely psychiatric 
malingering within a neurological sample.  Finally, future research should include 
designs that compare the M-FAST to methods of assessing malingering other than 
interviews, such as written self-report. 
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